Keyphrases
Technology Support
100%
Immune Checkpoint Inhibitors
100%
Checkpoint Inhibitors
100%
Monitoring System
100%
IrAE
100%
Immune Checkpoint Inhibitors Side Effects
50%
Oncologists
50%
Disease Survival
50%
Disease Progression
50%
Colitis
50%
Evidence-based
50%
Onset Timing
50%
Oncology
50%
Clinical Outcomes
50%
Metastatic Melanoma
50%
Patient Care
50%
Clinical Management
50%
Life-threatening
50%
Diarrhea
50%
Metastatic Lung Cancer
50%
Metastatic Renal Cell Carcinoma (mRCC)
50%
Patient Survival
50%
Cancer Progression
50%
Rash
50%
Inhibitor Treatment
50%
Cancer Treatment
50%
Caner
50%
Melanoma Cancer
50%
Medicine and Dentistry
Side Effect
100%
Immune Checkpoint Inhibitor
50%
Metastatic Melanoma
16%
Disease Exacerbation
16%
Kidney Cancer
16%
Colitis
16%
Diarrhea
16%
Exanthem
16%
Clinical Management
16%
Cancer Growth
16%
Lung Cancer
16%
Oncology
16%
Oncologist
16%
Cancer Therapy
16%